MATEON THERAPEUTICS INC (81) | Intellectual Property (5)

Browse by Subcategory

License Agreements (5 contracts)

Recent Contracts

License Agreement between Oncotelic Therapeutics, Inc. and GMP Biotechnology Limited dated March 31, 2022 (Filed With SEC on April 6, 2022)
License Agreement between Oncotelic Therapeutics, Inc. and Sapu Holdings, LLC dated March 31, 2022 (Filed With SEC on April 6, 2022)
License Agreement between Oncotelic Therapeutics, Inc. and Autotelic, Inc., dated September 30, 2021 (Filed With SEC on October 4, 2021)
License, Development and Commercialization Agreement between Mateon Therapeutics, Inc. and Windlas Biotech Private Limited dated November 10, 2020 (Filed With SEC on November 16, 2020)
Agreement for Delivery and Licensed Use of Data Generated from OT-101 U.S. Expanded Access (Data License 1) dated September 5, 2019 between WideTrial and Oncotelic (Filed With SEC on September 10, 2019)